Quick Answer
ORAMED PHARMACEUTICALS INC. reported Stockholders Equity of $199.74 million for fiscal year 2025.
ORAMED PHARMACEUTICALS INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $199.74M | +36.6% |
| 2024 | $146.26M | -10.7% |
| 2023 | $163.82M | +7.9% |
| 2022 | $151.81M | -8.8% |
| 2021 | $166.45M | +43.8% |
| 2021 | $115.77M | +252.1% |
| 2020 | $32.88M | +69.5% |
| 2019 | $19.39M | -37.7% |
| 2018 | $31.11M | +61.7% |
| 2017 | $19.24M | -26.5% |
| 2016 | $26.19M | +5.5% |
| 2015 | $24.83M | +19.4% |
| 2014 | $20.79M | +155.7% |
| 2013 | $8.13M | +115.2% |
| 2012 | $3.78M | +1.5% |
| 2011 | $3.72M | +348.4% |
| 2010 | $830.3K | -69.8% |
| 2009 | $2.75M | -40.2% |
| 2008 | $4.59M | +795.1% |
| 2007 | $513.1K | +855.6% |
| 2002 | $53.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $203.28M | +29.9% | +31.5% |
| June 30, 2025 | $154.53M | -12.7% | +9.7% |
| March 31, 2025 | $140.81M | -15.5% | -3.7% |
| December 31, 2024 | $146.26M | -10.7% | -6.5% |
| September 30, 2024 | $156.44M | +4.9% | -11.6% |
| June 30, 2024 | $177.06M | +16.8% | +6.3% |
| March 31, 2024 | $166.64M | +10.4% | +1.7% |
| December 31, 2023 | $163.82M | +7.9% | +9.8% |
- ORAMED PHARMACEUTICALS INC. showed an increase of +36.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2002–2025 period, ORAMED PHARMACEUTICALS INC.’s stockholders equity has grown by 371862.8% (from $53.7 thousand to $199.74 million).
- The most recent figure is from ORAMED PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: